RT-102(Rani)

N/A

Report date: 2022/03/29 09:09:07

Base Information

Drug NameRT-102(Rani)
Drug Alias Namehuman parathyroid hormone analog PTH(1-34)RT-102
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionCalcium sensing receptor agonistsParathyroid hormone receptor agonistsParathyroid hormone replacements +[4] 
TargetsCalcium sensing receptorParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRani Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesRani Therapeutics LlcRani Therapeutics Holdings Inc
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A